Other News

RapidAI Acclaimed by Frost & Sullivan for Its AI-powered Modular Stroke Platform

The technology used in the Rapid® platform is highly unique and scalable and can deliver exceptional cost efficiencies to hospitals of all sizes SANTA CLARA, Calif., Feb. 10, 2021 /PRNewswire/ — Based on its recent analysis of the global intelligent imaging analysis systems market, Frost & Sullivan recognizes RapidAI with the 2020 Global Growth, Innovation & […]

First patient treated in CereVasc clinical trial of eShunt™ System for communicating hydrocephalus

Investigational device has the potential to transform a half-century-old standard of care BOSTON, Feb. 10, 2021 /PRNewswire/ — CereVasc, Inc., a clinical-stage, medical device company developing novel, minimally invasive treatments for neurological diseases, has treated the first patient in a study of its eShunt System, an investigational device intended to treat communicating […]

CardiacSense Medical Grade Watch receives CE Mark for continuous detection of Atrial Fibrillation

– The watch will begin shipping in EU as a medical device for continuous measurement of heart rate and arrhythmias at ECG-level accuracy CAESAREA, Israel, Feb. 10, 2021 /PRNewswire/ —  CardiacSense – a digital health company that developed and clinically verified a medical grade watch capable of detecting and remotely monitoring Atrial Fibrillation (A-Fib) and Heart […]

New Study Published in JACC Clinical EP Validates that Cardiologs’ AI Eliminates Nearly Two-Thirds of False Positives in Remote Monitoring for Atrial Fibrillation

PARIS and BOSTON, Feb. 10, 2021 /PRNewswire/ — Cardiologs, a global leader in artificial intelligence (AI) cardiology diagnostics, today announced that results of a clinical study the company conducted in collaboration with Valley Health System have been published in the Journal of the American College of Cardiology Clinical Electrophysiology (“JACC Clinical EP”). The findings show […]

First Patient Enrolled in SELUTION SLR™ SUCCESS PTA Study

NYON, Switzerland, Feb. 10, 2021 /PRNewswire/ — MedAlliance has announced enrolment of the first patient in SUCCESS PTA, its large post-market study with the drug-eluting balloon SELUTION SLR™ for the treatment of patients with peripheral artery disease (PAD). SELUTION SLR is a novel sirolimus-eluting balloon that provides a controlled sustained release of drug, […]

MedLumics closes upsized EUR 18M (21.7M USD) financing round and appoints new Chairman

– MedLumics’ oversubscribed financing round closes at EUR 18M to advance optically-guided real-time ablation catheter technology for the treatment of Atrial Fibrillation – MedTech veteran, Rich Ferrari, joins MedLumics’ Board of Directors as new Chairman MADRID, Feb. 10, 2021 /PRNewswire/ — MedLumics, a privately held medical device company developing AblaView®, the first […]

United Therapeutics Announces Commercial Launch Of The Remunity® Pump For Remodulin®

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Feb. 10, 2021 /PRNewswire/ — United Therapeutics Corporation (Nasdaq: UTHR) announced today that it has launched commercial sales of the innovative Remunity® Pump for Remodulin® for patients with pulmonary arterial hypertension (PAH). “We are excited to bring to market the first subcutaneous pump designed specifically for PAH patients,” said Beth Rhodes, […]

IME Medical Electrospinning and STENTiT enter into development cooperation on resorbable endovascular support grafts to regenerate vascular tissue

WAALRE, Netherlands, Feb. 10, 2021 /PRNewswire/ — IME Medical Electrospinning, a global leader in electrospun medical devices, today announced that it has entered into a collaboration with Dutch medical device company STENTiT, to join forces in the further development and production of regenerative endovascular support grafts (see video). These resorbable fibrous implants hold the promise to rebuild […]

Neovasc Announces US$72 Million Registered Direct Offering Priced At-The-Market

Vancouver, Canada, Feb. 10, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Neovasc Inc. (“Neovasc” or the “Company”) (Nasdaq: NVCN / TSX: NVCN) announced today that it has entered into definitive agreements with certain healthcare-focused institutional investors for the sale of an aggregate of 36,000,000 common shares at a purchase price of US$2.00 […]

Itamar Medical Announces Closing of Public Offering of American Depositary Shares and Full Exercise of the Underwriters’ Option to Purchase Additional ADSs

CAESAREA, Israel, Feb. 10, 2021 (GLOBE NEWSWIRE) — Itamar Medical Ltd. (“Itamar Medical” or the “Company”) (Nasdaq: ITMR) (TASE: ITMR), a medical technology company focused on the development and commercialization of non-invasive medical devices to aid in the diagnosis of respiratory sleep disorders, today announced the closing of its public […]